Helixmith Co., Ltd

KOSDAQ:A084990 Voorraadrapport

Marktkapitalisatie: ₩170.4b

Helixmith Inkomsten in het verleden

Verleden criteriumcontroles 0/6

Helixmith has been growing earnings at an average annual rate of 13.2%, while the Biotechs industry saw earnings growing at 7.2% annually. Revenues have been declining at an average rate of 3.9% per year.

Belangrijke informatie

13.2%

Groei van de winst

21.0%

Groei van de winst per aandeel

Biotechs Groei van de industrie11.7%
Inkomstengroei-3.9%
Rendement op eigen vermogen-36.8%
Nettomarge-1,717.4%
Laatste winstupdate30 Jun 2024

Recente prestatie-updates uit het verleden

Recent updates

Helixmith (KOSDAQ:084990) Is In A Good Position To Deliver On Growth Plans

Oct 18
Helixmith (KOSDAQ:084990) Is In A Good Position To Deliver On Growth Plans

Would Shareholders Who Purchased Helixmith's (KOSDAQ:084990) Stock Three Years Be Happy With The Share price Today?

Feb 19
Would Shareholders Who Purchased Helixmith's (KOSDAQ:084990) Stock Three Years Be Happy With The Share price Today?

Opbrengsten en kosten

Hoe Helixmith geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

KOSDAQ:A084990 Opbrengsten, kosten en inkomsten (KRW Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 243,169-54,42314,71810,858
31 Mar 243,548-58,62815,36513,964
31 Dec 234,202-64,08818,84417,145
30 Sep 234,415-38,21418,47124,101
30 Jun 234,092-41,01521,35826,438
31 Mar 233,497-42,09922,91028,389
31 Dec 222,800-43,53823,29928,101
30 Sep 222,892-55,43424,99430,804
30 Jun 222,774-48,65023,47128,588
31 Mar 222,701-61,86323,52125,752
31 Dec 212,316-66,00523,00025,297
30 Sep 212,430-43,72915,51422,522
30 Jun 212,737-55,09817,84724,439
31 Mar 213,799-57,43221,02035,574
31 Dec 204,248-65,38019,03137,419
30 Sep 204,967-159,38620,37340,511
30 Jun 205,367-153,31319,96337,009
31 Mar 204,827-114,48816,67526,082
31 Dec 194,455-106,88517,20221,474
30 Sep 193,653-29,88823,88510,631
30 Jun 193,015-26,22921,4819,769
31 Mar 193,119-41,93917,9797,490
31 Dec 183,127-27,40314,2596,390
30 Sep 183,154-13,25310,1685,739
30 Jun 183,268-8,2636,8874,914
31 Mar 183,235-7,1895,8484,106
31 Dec 173,158-6,4965,4533,845
30 Sep 145,205-2,6104,311478
30 Jun 145,484-8424,199381
31 Mar 145,394-904,056452
31 Dec 135,7462663,954438

Kwaliteitswinsten: A084990 is currently unprofitable.

Groeiende winstmarge: A084990 is currently unprofitable.


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: A084990 is unprofitable, but has reduced losses over the past 5 years at a rate of 13.2% per year.

Versnelling van de groei: Unable to compare A084990's earnings growth over the past year to its 5-year average as it is currently unprofitable

Winst versus industrie: A084990 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (6.1%).


Rendement op eigen vermogen

Hoge ROE: A084990 has a negative Return on Equity (-36.85%), as it is currently unprofitable.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden